PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pralsetinib

Genentech' Gavreto (pralsetinib) Receives the US FDA's Approval Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Genentech' Gavreto (pralsetinib) Receives the US FDA's Approval Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

September 7, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us